The challenges of developing and manufacturing GMP peptides can often be a significant obstacle to developers. Fortunately, Contract Development and Manufacturing Organizations (CDMOs) have emerged as valuable partners in this sector. With specialized expertise and state-of-the-art facilities, CDMOs can accelerate the development process, enabling